SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Fermi, Inc. engages in the development of energy infrastructure. It intends to develop an energy and data center development campus to support the needs of to-be-built AI infrastructure. The company was founded by Rick Perry, Toby Neugebauer and Griffin Perry on January 10, 2025 and is headquartered in Amrillo, TX.

Fermi Inc

Fermi LLC

Fermi LLC is trending as investors react to a significant uptick in volume and intense social media speculation surrounding potential anchor tenant negotiations, all while the company aggressively pursues expansion milestones like recent turbine deliveries at the Port of Houston. Community sentiment remains polarized, with many users debating whether the stock's recent volatility and capital-raising activities indicate a strategic setup for a major breakout or if the lack of formal partnership updates signals continued downside risk.

Ambarella, Inc. engages in the development of low-power system-on-a-chip (SoC), semiconductors, and software for edge artificial intelligence (AI) applications and intelligent automation. The firm's products include video security, advanced driver assistance (ADAS), electronic mirror, drive recorder, driver or cabin monitoring, autonomous driving, and other robotics applications. It operates through the following geographical segments: Taiwan, Asia Pacific, Europe, North America, and United States. The company was founded by Feng Ming Wang and Leslie D. Kohn on January 15, 2004 and is headquartered in Santa Clara, CA.

Ambarella Inc

Ambarella is seeing high volatility and intense community discussion following reports of a potential acquisition by NXP Semiconductors, a move seen by many as a strategic play to bolster NXPs automotive AI and edge computing portfolio. While investors are debating the merits of a buyout premium against the uncertainties of such a complex deal, active traders are closely watching the stock's significant volume and technical price swings.

Luckin Coffee, Inc. engages in providing food and beverage items, and operates coffee retail stores. It has a pioneered a technology-driven retail network to provide coffee and other products of high quality, high convenience and high affordability to customers. The company manages pick-up stores, relax stores, and delivery kitchens. It also offers tea, snacks, and light meals through its mobile application. The company was founded by Zhi Ya Qian, Fei Yang and Jin Yi Guo on June 16, 2017 and is headquartered in Xiamen, China.

Luckin Coffee Inc - ADR

Investors are closely tracking Luckin Coffee's upcoming quarterly results, with the community actively debating whether the company can sustain its rapid expansion and store growth while managing margins. Bullish sentiment is being bolstered by recent partnerships and consistent store count increases, fueling speculation among longs about potential relisting news and a breakthrough toward higher price levels.

Replimune Group, Inc. is a clinical-stage biotechnology company. It engages in the business of developing oncolytic immunotherapies for the treatment of cancer. The company was founded by Philip Astley-Sparke, Colin A. Love, and Robert Coffin in March 2015 and is headquartered in Woburn, MA.

Replimune Group Inc

Replimune Group is facing significant volatility as recently released FDA briefing documents suggest a third potential rejection for its melanoma treatment, citing concerns over flawed study design and inflated efficacy data. The market reaction reflects high uncertainty leading up to the upcoming advisory committee meeting, with investors actively debating the likelihood of approval versus another complete response letter.

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980 and is headquartered in Cambridge, MA.

Sarepta Therapeutics Inc

Sarepta Therapeutics is experiencing significant volatility and intense community discussion surrounding its recent leadership transition to CEO Michael Severino, with investors debating whether this signals a potential turnaround or a shift away from imminent buyout hopes. While some in the community highlight the stock's deep valuation discount relative to its revenue and commercial pipeline, others remain frustrated by persistent downward price pressure and the company's struggle to maintain positive momentum despite sector-wide movements.

Omeros Corp. operates as a biopharmaceutical company, which engages in the research, discovery, development, and commercialization of small-molecule and protein therapeutics targeting immunologic diseases. It also offers orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.

Omeros Corporation

Omeros Corp

Omeros Corp is trending as investors react to the company's recent strategic debt repurchases, which signal management's confidence in near-term cash flow and future milestones, while community sentiment remains focused on upcoming European regulatory decisions and the activation of the permanent billing J-code. Shareholders are actively debating the timing of potential partnership payments and whether these financial moves indicate that the company is effectively de-risking ahead of a larger strategic event.

United States Oil Fund LP - United States Oil Fund

United States Oil Fund

The United States Oil Fund is facing significant volatility as market participants weigh persistent geopolitical tensions in the Strait of Hormuz against ongoing speculation regarding U.S.-Iran diplomatic interventions. The community is actively debating whether recent price fluctuations are driven by genuine supply shortages and regional escalation or by government-led market manipulation to influence domestic inflation.

Pagaya Technologies Ltd. engages in the development of AI and data networks for the financial industry. Its product deploys data science, machine learning and AI technology to evaluate the customers' applications in real time. The company was founded by Gal Krubiner, Sanjiv Das, Yahav Yulzari, and Avital Pardo on March 20, 2016 and is headquartered in New York, NY.

Pagaya Technologies Ltd - Ordinary Shares - Class A

Pagaya Technologies Ltd

Pagaya Technologies is trending as investors react to a positive second-quarter earnings report, which featured a double beat on top and bottom-line estimates and raised full-year guidance. The community is actively discussing the stock's significant short interest, recent analyst price target upgrades, and a broader bullish sentiment driven by strong ABS issuance and the company's ability to maintain profitability despite macroeconomic uncertainty.

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsværd, Denmark.

Novo Nordisk - ADR

Novo Nordisk A/S

Novo Nordisk is trending as investors weigh strong demand for its oral Wegovy pipeline against the company's aggressive legal challenge to Eli Lilly's advertising claims. The community is actively debating the durability of the oral drug's prescription growth as a primary catalyst, with many shareholders maintaining a long-term bullish stance despite recent share price volatility.

Oxford Lane Capital Corp. is a closed-end management investment company, which engages in investing in debt and equity tranches of collateralized loan obligation vehicles. The company was founded on June 9, 2010 and is headquartered in Greenwich, CT.

Oxford Lane Capital Corp

Oxford Lane Capital is seeing significant volatility as investors digest a disappointing earnings report, reduced dividend payouts, and concerns over the company's private credit and CLO strategy. The community remains deeply divided, with some investors debating management's long-term transparency and the sustainability of the fund's net asset value, while others discuss the potential for a rebound driven by high yields.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Neutral Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	N/A
Prev Close	N/A
Open	N/A
Dividend Yield	N/A
50-Day Moving Average	N/A
Beta	N/A
Avg. Volume	N/A
PE Ratio	N/A

52-Week High	N/A
52-Week Low	N/A
Market Capitalization	N/A
EPS (Annual)	N/A
Price to Book	N/A
Revenue Per Employee	N/A

Feed

News

Sentiment

Fundamentals

Info